Tricomin Review
- January 18th, 2008
- Posted in Tricomin
- Write comment
Tricomin is a variety of hair solutions consisting of conditioner, shampoo, deep cleansing cream and Follicle Therapy Spray. The spray is the range’s flagship merchandise that has beneficial results towards hair loss.
This unique product is unique in that it uses Copper Peptides technology as a hair development stimulant. It is a great addition to your hair loss regime.
What makes it work?
Copper Peptides has been proven to inhibit the enzyme 5 alpha reductase (5AR) which is responsible for the creation of DHT. As you age, the amount of copper peptides in your body will decrease, permitting free 5AR enzymes to convert Testosterone to DHT.
By delivering Copper Peptides directly for the follicles, Tricomin can enhance development by stimulating the follicles from the resting phase (ANAGEN) to the growing phase again (TELOGEN). That in turn will increase the hair’s development and reduce fallout.
The spray has potential to decrease the amounts of DHT buildup on the scalp.
What are the Side Effects?
No known side consequences have been attributed while making use of Tricomin variety of products and solutions.
Who should use this?
The Follicle Therapy Spray is most effectively used as a supplemental addition to your regime. If you might be looking for a shampoo in addition to a conditioner, you can try the Tricomin variety. It is suitable for gentle cleansing of the scalp and assists the follicle spray in maximizing copper peptide penetration.
The scalp conditioner can relieve discomfort to those who don’t tolerate Minoxidil quite well.
How to use it effectively?
If you are applying the Follicle Therapy Spray, it’s pretty simple to make use of. Just spray liberally all over thinning area after shampooing. It’s best to make use of this merchandise in the morning and also in the evenings before heading to bed. If you will be employing the rest on the Tricomin items, just follow the instructions and use just like your normal shampoo and conditioner.

No comments yet.